Rocephin (Ceftriaxone) for Uncomplicated Gonorrhea
For uncomplicated urogenital gonorrhea, give ceftriaxone 500 mg IM once PLUS doxycycline 100 mg orally twice daily for 7 days if chlamydia has not been excluded. This represents the most current evidence-based approach that balances treatment efficacy with antimicrobial stewardship 1, 2.
Primary Treatment Regimen
The 2020 CDC update increased the recommended dose from 250 mg to 500 mg based on:
- Stable ceftriaxone MICs in U.S. surveillance (<0.1% with alert values >0.25 mcg/mL)
- Rising azithromycin resistance (nearly 5% with elevated MICs ≥2.0 mcg/mL by 2018)
- Antimicrobial stewardship concerns about dual therapy's impact on commensal organisms 1, 2
The 500 mg dose treats all anatomic sites effectively: urogenital, anorectal, AND pharyngeal infections with a single injection 1.
Key Dosing Details from FDA Label:
- Standard adult dose: 500 mg IM as single dose for uncomplicated gonorrhea 3
- Historical dose: 250 mg IM (older guidelines, now superseded) [4-4]
- Administration: Deep IM injection into large muscle mass with aspiration to avoid vascular injection 3
Pharyngeal Infection Considerations
Pharyngeal gonorrhea requires the same 500 mg IM ceftriaxone dose - this is critical because:
- Pharyngeal infections are harder to eradicate than urogenital sites
- The pharynx serves as a reservoir for transmission (via kissing, saliva as lubricant, oral-genital contact) 5
- The pharynx is a key site for antimicrobial resistance emergence 5
- Most ceftriaxone treatment failures involve pharyngeal infections 5
Common pitfall: The older 250 mg dose may be insufficient for pharyngeal infections, particularly with emerging resistance patterns. The 500 mg dose provides adequate coverage 1, 2.
Severe Cephalosporin Allergy Alternatives
If the patient has a severe cephalosporin allergy, use azithromycin 2 g orally as a single dose PLUS mandatory test-of-cure in 1 week [4-4].
Critical Management Steps for Allergic Patients:
Confirm true allergy: Many reported "allergies" are not IgE-mediated
If using azithromycin 2 g:
- Expect significant GI distress (common side effect)
- Test-of-cure at 1 week is NON-NEGOTIABLE
- Use culture if available, or NAAT if culture unavailable
- If NAAT positive, confirm with culture 4
Alternative if ceftriaxone unavailable (not allergy): Cefixime 400 mg orally PLUS azithromycin 1 g orally PLUS test-of-cure in 1 week [4-4]
Warning: There are essentially no good alternatives for pharyngeal gonorrhea in cephalosporin-allergic patients. Gentamicin and spectinomycin have poor pharyngeal efficacy 5, 2, 6.
Treatment Failure Management
If a patient returns with persistent infection after recommended therapy:
- Culture the specimen immediately with antimicrobial susceptibility testing 4
- Report to local/state health department within 24 hours 4
- Consult infectious disease specialist 4
- Consider: Gentamicin 240 mg IM PLUS azithromycin 2 g orally (per 2021 CDC guidance) 5
- Retain isolate for further testing 4
Chlamydia Co-treatment
Add doxycycline 100 mg orally twice daily for 7 days if chlamydia has not been excluded 1, 2. This replaced the previous dual therapy approach with azithromycin, which:
- Was used to prevent ceftriaxone resistance (theoretical benefit)
- Contributed to rising azithromycin resistance
- Impacted commensal organisms unnecessarily 1, 2
Note: Ceftriaxone has NO activity against Chlamydia trachomatis 3.
Important Caveats
- Neonates: Ceftriaxone is contraindicated in neonates ≤28 days receiving calcium-containing IV solutions due to precipitation risk 3
- Partner treatment: Ensure all sexual partners from preceding 60 days are evaluated and treated 4
- Resistance monitoring: Continue surveillance through culture capacity maintenance, as NAATs cannot assess antimicrobial susceptibility 4
- No dose adjustment needed for renal or hepatic impairment 3